The treatment of ductal carcinoma in situ
10.3760/cma.j.issn.1673-4904.2017.04.024
- VernacularTitle:乳腺导管原位癌的治疗现状
- Author:
Xue DU
;
Jianguo ZHANG
- Keywords:
Carcinoma,ductal,breast;
Sentinel lymph node biopsy;
Radiotherapy,computer-assisted;
Endocrine therapy
- From:
Chinese Journal of Postgraduates of Medicine
2017;40(4):376-378
- CountryChina
- Language:Chinese
-
Abstract:
Ductal carcinoma in situ belongs to the early stage of breast cancer.The treatment of ductal carcinoma in situ is similar with that of the breast cancer.Because of the low mortality rate in patients with ductal carcinoma in situ,there was an excessive treatment in the treatment of ductal carcinoma in situ.So the key to the treatment of ductal carcinoma in situ was to improve the quality of life.The present study shows that the effect of conserving surgery with radiotherapy is same with mastectomy's in the treatment of breast ductal carcinoma in situ.Sentinel lymph node biopsy can also be used to evaluate the patient's axillary status.For patients with ductal carcinoma in situ with breast conserving surgery,radiotherapy and endocrine therapy can reduce the recurrence rate of ipsilateral breast cancer.Radiotherapy and endocrine therapy have also become the standard treatment for ductal carcinoma in situ.
